Showing results (121-130 of 148) with videos related to
Sort By:
Pageof 15
Biochemical Society Symposium|July 13, 2001
Apolipoprotein E and beta A4-amyloid: signals and effectsT G Ohm, U Hamker, A Cedazo-Minguez, et al.The European Journal of Neuroscience|December 14, 1999
Morphological, immunophenotypical and electrophysiological properties of resting microglia in vitroC Eder, T Schilling, U Heinemann, et al.Glia|August 15, 2000
Phagocytosis of neuronal or glial debris by microglial cells: upregulation of MHC class II expression and multinuclear giant cell formation in vitroM Beyer, U Gimsa, I Y Eyüpoglu, et al.Neuroscience|August 30, 2003
Cholecystokinin expression after hippocampal deafferentiation: molecular evidence revealed by differential display-reverse transcription-polymerase chain reactionA U Bräuer, N E Savaskan, M Plaschke, et al.Cellular and Molecular Life Sciences : CMLS|April 28, 2004
Myelination in the hippocampus during development and following lesionS Meier, A U Bräuer, B Heimrich, et al.Neuroscience|October 1, 1997
Cholinergic sprouting in the rat fascia dentata after entorhinal lesion is not linked to early changes in neurotrophin messenger RNA expressionE Förster, T Naumann, T Deller, et al.Glia|September 7, 2000
Reactive astrocytes upregulate Fas (CD95) and Fas ligand (CD95L) expression but do not undergo programmed cell death during the course of anterograde degenerationI Bechmann, S Lossau, B Steiner, et al.Glia|July 13, 1999
FasL (CD95L, Apo1L) is expressed in the normal rat and human brain: evidence for the existence of an immunological brain barrierI Bechmann, G Mor, J Nilsen, et al.The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|October 12, 1999
A role for the Eph ligand ephrin-A3 in entorhino-hippocampal axon targetingE Stein, N E Savaskan, O Ninnemann, et al.Neuroscience|August 23, 2001
Regulation of apolipoprotein E secretion in rat primary hippocampal astrocyte culturesA Cedazo-Mínguez, U Hamker, V Meske, et al.Pageof 15